Aldeyra Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aldeyra Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
  • Aldeyra Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 59.4M shares, a 1.04% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 59.4M +613K +1.04% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 59.4M +623K +1.06% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 59.2M +636K +1.09% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 59.2M +627K +1.07% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 58.8M +500K +0.86% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 58.8M +490K +0.84% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 58.6M +479K +0.82% Dec 31, 2022 10-K 2024-03-07
Q3 2022 58.6M +19.9M +51.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 58.3M +19.6M +50.8% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 58.3M +19.6M +50.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 58.1M +19.4M +50.2% Dec 31, 2021 10-K 2023-03-09
Q3 2021 38.7M +35.8K +0.09% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 38.7M +5.67M +17.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 38.7M +9.16M +31% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 38.7M +10M +34.9% Dec 31, 2020 10-K 2022-03-17
Q3 2020 38.6M +11.5M +42.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 33M +6.01M +22.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 29.5M +2.6M +9.65% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 28.7M +2.41M +9.19% Dec 31, 2019 10-K 2021-03-11
Q3 2019 27.2M +6.16M +29.4% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 27M +6.14M +29.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 26.9M +7.25M +36.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 26.2M +7.11M +37.1% Dec 31, 2018 10-K 2020-03-12
Q3 2018 21M +1.87M +9.79% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 20.8M +5.69M +37.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 19.7M +4.53M +30% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 19.1M +6.56M +52.2% Dec 31, 2017 10-K 2019-03-08
Q3 2017 19.1M +6.55M +52.1% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 15.2M +2.68M +21.5% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 15.1M +5.42M +55.8% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 12.6M +2.86M +29.5% Dec 31, 2016 10-K 2018-03-29
Q3 2016 12.6M +2.86M +29.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 12.5M +2.76M +28.4% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 9.71M +2.82M +41% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 9.71M +4.15M +74.5% Dec 31, 2015 10-K 2017-03-30
Q3 2015 9.71M +4.15M +74.5% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 9.71M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 6.89M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 5.57M +5.24M +1600% Dec 31, 2014 10-K 2016-03-30
Q3 2014 5.57M Sep 30, 2014 10-Q 2014-11-12
Q4 2013 327K Dec 31, 2013 10-Q 2014-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.